Navigation Links
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Date:6/2/2009

Bionovo at a very fitting moment, when my experience, technical knowledge and regulatory understanding can greatly contribute to the company's success. I believe Menerba is a groundbreaking product that will provide a safer treatment for women suffering from menopausal symptoms, and I look forward to contributing to its successful development."

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may ca
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108
2. Bionovo Announces 2008 Highlights and Year-End Financial Results
3. Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
4. Bert W. OMalley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovos Scientific Advisory Board
5. Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform
6. Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
7. Bionovo to Present at the Piper Jaffray Healthcare Conference
8. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Reports Third Quarter 2008 Financial Results
10. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
11. Bionovo to Present at Canaccord Adams Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Recognizing exciting ... faculty members to its 2013 Class of Young ... company will provide this outstanding international group with ... advancing basic science to meet global challenges.     , ... help promising young and untenured research faculty working ...
(Date:5/19/2013)... Switzerland’s MS Tûranor PlanetSolar , ... speed record for a transatlantic crossing by a solar ... April 25, 2013, the solar powered boat sailed 2,867miles ... speed of 5.3 knots before reaching Marigot, St. Martin, ... The first-of-its-kind catamaran completed this year’s passage across the ...
(Date:5/17/2013)... when the transplant recipient,s immune system identifies the transplanted ... previously thought that T cells, the immune cells that ... as chemokines in order to migrate to the transplanted ... Clinical Investigation , Fadi Lakkis and colleagues at the ... stimulation of T cells is not required for migration. ...
(Date:5/17/2013)... PHILADELPHIA , May 17, 2013 ... held by the most innovative thought leaders of ... Device & Manufacturing East conference and expo, from ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) ... were designed to deliver industry professionals practical presentations ...
Breaking Biology Technology:DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2
... JERUSALEM , May 18, 2010 ... MD, joins Oramed,Pharmaceuticals, Board of Directors. Dr. Berelowitz is currently Senior Vice,President ... Unit at Pfizer, Inc., the world,s largest,research-based pharmaceutical company. , ... Dr. Berelowitz joined ...
... Pfizer Global Manufacturing announced today plans to reconfigure its ... supply organization from the combined networks of Pfizer (NYSE: ... phase of Pfizer,s previously announced Plant Network Strategy includes recommendations ... , Puerto Rico , and the United States ...
... 2010 , , , ... , , , ... cleared by FDA for Home/Self use and is,consequently available to all patients with home hemodialysis ... use has already improved in-clinic patient,safety. Optimizing safety conditions for home hemodialysis users is a ...
Cached Biology Technology:Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors 2Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors 3Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network 2Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network 3Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network 4Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network 5Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network 6Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network 7Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis 2
(Date:5/16/2013)... 17, 2013) Illustrating a commitment to the ... Gastroenterological Association (AGA) Research Foundation has announced the ... Fellowship Award recipients. Supported by the National Institute ... this new award helps underrepresented minority students to ... nutrition research. , "By establishing this new award, ...
(Date:5/16/2013)... closer to a fast food restaurant had a higher ... away from fast food, according to researchers at The ... association was particularly strong among those with a lower ... the American Journal of Public Health indicates ... food restaurant, and among lower-income African-Americans, the density, or ...
(Date:5/16/2013)... nanoparticles developed at MIT may someday eliminate the ... constantly monitor their blood-sugar levels and inject themselves ... sense glucose levels in the body and respond ... replacing the function of pancreatic islet cells, which ... Ultimately, this type of system could ensure that ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... Zurich, Switzerland, August 18, 2009 / b3c newswire ... that, following the successful completion of key research ... disease has advanced into preclinical development, triggering milestone ... (NASDAQ: BIIB). Neurimmune partnered with Biogen Idec for ...
... Why is it that you can instantly recall your own phone ... a new number you heard a few moments ago? The two ... long-term and short-term, respectively that are stored very differently ... the animal kingdom, even in insects such as the fruit fly. ...
... by lightning strikes, Victor Ugaz, associate professor in the ... University, has created a network of microchannels that could ... a three-dimensional vasculature for the support of larger tissue ... undertaken with colleague Arul Jayaraman and appears in the ...
Cached Biology News:Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 3CSHL study finds short- and long-term memories require same gene but in different circuits 2CSHL study finds short- and long-term memories require same gene but in different circuits 3Researcher says microchannels could advance tissue engineering methods 2Researcher says microchannels could advance tissue engineering methods 3Researcher says microchannels could advance tissue engineering methods 4
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2) (67 kDa neutrophil oxidase factor) (p67-phox) (NOXA2). [Source:Uniprot/SWISSPROT;Acc:P19878] Antigen: Recombinant Protein E...
Rabbit polyclonal to MA2 ( Abpromise for all tested applications). entrezGeneID: 10687 SwissProtID: Q9UL42...
... Rabbit polyclonal to FANCM ( Abpromise ... Antigen: Synthetic peptide derived from ... Human FANCM. (Note: the amino acid ... available as ab27787 .) ...
Biology Products: